Inflammation biomarkers and delirium in critically ill patients

Critical Care

Volumn 18, Issue 3, 2014, Pages

  Ritter, Cristiane ^a,b   Tomasi, Cristiane D ^a   Dal Pizzol, Felipe ^a,b,c   Pinto, Bernardo B ^d,e   Dyson, Alex ^d   de Miranda, Aline S ^f   Comim, Clarissa M ^a   Soares, Márcio ^g,h   Teixeira, Antonio L ^f   Quevedo, João ^a,i   Singer, Mervyn ^d  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b HOSPITAL SÃO JOSÉ   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF PORTO   (Portugal)

^f FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^g D OR INSTITUTE FOR RESEARCH AND EDUCATION IDOR   (Brazil)

^h INSTITUTO NACIONAL DE CÂNCER   (Brazil)

ⁱ UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; APACHE; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DELIRIUM; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEDATION; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; AGED; BLOOD; CRITICAL ILLNESS; INTENSIVE CARE UNIT; MIDDLE AGED; TRENDS;

ADULT; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; CRITICAL ILLNESS; DELIRIUM; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84902658606     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13887     Document Type: Article

References (46)

1. Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE, Inouye SK, Bernard GR, Dittus RS. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004, 291:1753-1762. 10.1001/jama.291.14.1753, 15082703.
2. Girard TD, Pandharipande PP, Ely EW. Delirium in the intensive care unit. Crit Care 2008, 12:S3.
3. Grandi C, Tomasi CD, Fernandes K, Stertz L, Kapczinski F, Quevedo J, Dal-Pizzol F, Ritter C. Brain-derived neurotrophic factor and neuron-specific enolase, but not S100β, levels are associated to the occurrence of delirium in intensive care unit patients. J Crit Care 2011, 26:133-137. 10.1016/j.jcrc.2010.10.006, 21106342.
4. Hughes CG, Morandi A, Girard TD, Riedel B, Thompson JL, Shintani AK, Pun BT, Ely EW, Pandharipande PP. Association between endothelial dysfunction and acute brain dysfunction during critical illness. Anesthesiology 2013, 118:631-639. 10.1097/ALN.0b013e31827bd193, 3580006, 23263016.
5. Pandharipande PP, Morandi A, Adams JR, Girard TD, Thompson JL, Shintani AK, Ely EW. Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients. Intensive Care Med 2009, 35:1886-1892. 10.1007/s00134-009-1573-6, 3673700, 19588122.
6. Morandi A, Gunther ML, Pandharipande PP, Jackson JC, Thompson JL, Shintani AK, Ely EW, Girard TD. Insulin-like growth factor-1 and delirium in critically ill mechanically ventilated patients: a preliminary investigation. Int Psychogeriatr 2011, 23:1175-1181. 10.1017/S1041610210002486, 3654518, 21294938.
7. Pandharipande PP, Sanders RD, Girard TD, McGrane S, Thompson JL, Shintani AK, Herr DL, Maze M. Ely EW; MENDS investigators: Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care 2010, 14:R38. 10.1186/cc8916, 2887145, 20233428.
8. McGrane S, Girard TD, Thompson JL, Shintani AK, Woodworth A, Ely EW, Pandharipande PP. Procalcitonin and C-reactive protein levels at admission as predictors of duration of acute brain dysfunction in critically ill patients. Crit Care 2011, 15:R78. 10.1186/cc10070, 3219330, 21366899.
9. van den Boogaard M, Kox M, Quinn KL, van Achterberg T, van der Hoeven JG, Schoonhoven L, Pickkers P. Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients. Crit Care 2011, 15:R297. 10.1186/cc10598, 3388649, 22206727.
10. Kiehntopf M, Schmerler D, Brunkhorst FM, Winkler R, Ludewig K, Osterloh D, Bloos F, Reinhart K, Deufel T. Mass spectometry-based protein patterns in the diagnosis of sepsis/systemic inflammatoryresponse syndrome. Shock 2011, 36:560-569. 10.1097/SHK.0b013e318237ea7c, 21993444.
11. Sutherland A, Thomas M, Brandon RA, Brandon RB, Lipman J, Tang B, McLean A, Pascoe R, Price G, Nguyen T, Stone G, Venter D. Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis. Crit Care 2011, 15:R149. 10.1186/cc10274, 3219023, 21682927.
12. Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother 2011, 66:33-40.
13. Mina F, Comim CM, Dominguini D, Cassol-Jr OJ, Dall Igna DM, Ferreira GK, Silva MC, Galant LS, Streck EL, Quevedo J, Dal-Pizzol F. Il1-β involvement in cognitive impairment after sepsis. Mol Neurobiol 2014, 49:1069-1076. 10.1007/s12035-013-8581-9, 24234155.
14. Griffin T, Skelly DT, Murray CL, Cunningham C. Cyclooxygenase-1-dependent prostaglandins mediate susceptibility to systemic inflammation-induced acute cognitive dysfunction. J Neurosci 2013, 33:15248-15258. 10.1523/JNEUROSCI.6361-11.2013, 3776067, 24048854.
15. Murray CL, Obiang P, Bannerman D, Cunningham C. Endogenous IL-1 in cognitive function and anxiety: a study in IL-1RI(-/-) mice. PLoS One 2013, 8:e78385. 10.1371/journal.pone.0078385, 3813582, 24205219.
16. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 2013, 13:862-874. 10.1038/nri3552, 24232462.
17. Vachharajani V, Cunningham C, Yoza B, Carson J, Vachharajani TJ, McCall C. Adiponectin deficiency exaggerates sepsis-induced microvascular dysfunction in the mouse brain. Obesity 2012, 20:498-504. 10.1038/oby.2011.316, 3288614, 21996662.
18. Ely EW, Margolin R, Francis J, May L, Truman B, Dittus R, Speroff T, Gautam S, Bernard GR, Inouye SK. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med 2001, 29:1370-1379. 10.1097/00003246-200107000-00012, 11445689.
19. Levy MM, Fink MP, Marshall JC. SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 2001:1250-1256.
20. van Gool WA, van de Beek D, Eikelenboom P. Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet 2010, 375:773-775. 10.1016/S0140-6736(09)61158-2, 20189029.
21. Cohen O, Reichenberg A, Perry C, Ginzberg D, Pollmacher T, Soreq H, Yirmiya R. Endotoxin-induced changes in human working and declarative memory associate with cleavage of plasma 'readthrough' acetylcholinesterase. J Mol Neurosci 2003, 21:199-212. 10.1385/JMN:21:3:199, 14645987.
22. Krabbe KS, Reichenberg A, Yirmiya R, Smed A, Pedersen BK, Bruunsgaard H. Low-dose endotoxemia and human neuropsychological functions. Brain Behav Immun 2005, 19:453-460. 10.1016/j.bbi.2005.04.010, 15963684.
23. Munster BC, Aronica E, Zwinderman AH, Eikelenboom P, Cunningham C, Rooij SE. Neuroinflammation in delirium: a postmortem case-control study. Rejuvenation Res 2011, 14:615-622. 10.1089/rej.2011.1185, 21978081.
24. Girard TD, Ware LB, Bernard GR, Pandharipande PP, Thompson JL, Shintani AK, Jackson JC, Dittus RS, Ely EW. Associations of markers of inflammation and coagulation with delirium during critical illness. Intensive Care Med 2012, 38:1965-1973. 10.1007/s00134-012-2678-x, 3606929, 22903241.
25. Zhang Z, Pan L, Deng H, Ni H, Xu X. Prediction of delirium in critically ill patients with elevated C-reactive protein. J Crit Care 2014, 29:88-92. 10.1016/j.jcrc.2013.09.002, 24120090.
26. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007, 11:R49. 10.1186/cc5783, 2206478, 17448250.
27. Hanamsagar R, Hanke ML, Kielian T. Toll-like receptor (TLR) and inflammasome actions in the central nervous system. Trends Immunol 2012, 33:333-342. 10.1016/j.it.2012.03.001, 3383346, 22521509.
28. Imamura Y, Wang H, Matsumoto N, Muroya T, Shimazaki J, Ogura H, Shimazu T. Interleukin-1β causes long-term potentiation deficiency in a mouse model of septic encephalopathy. Neuroscience 2011, 187:63-69.
29. Terrando N. Rei Fidalgo A, Vizcaychipi M, Cibelli M, Ma D, Monaco C, Feldmann M, Maze M: The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction. Crit Care 2010, 14:R88. 10.1186/cc9019, 2911722, 20470406.
30. Sharshar T, Annane D, de la Grandmaison GL, Brouland JP, Hopkinson NS, Gray F. The neuropathology of septic shock. Brain Pathol 2004, 14:21-33.
31. Schliebs R, Heidel K, Apelt J, Gniezdzinska M, Kirazov L, Szutowicz A. Interaction of interleukin-1beta with muscarinic acetylcholine receptor-mediated signaling cascade in cholinergically differentiated SH-SY5Y cells. Brain Res 2006, 1122:78-85. 10.1016/j.brainres.2006.09.014, 17026971.
32. Alexander JJ, Jacob A, Cunningham P, Hensley L, Quigg RJ. TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem Int 2008, 52:447-456. 10.1016/j.neuint.2007.08.006, 3191465, 17884256.
33. Landoni VI. Schierloh P, de Campos Nebel M, Fernández GC, Calatayud C, Lapponi MJ, Isturiz MA: Shiga toxin 1 induces on lipopolysaccharide-treated astrocytes the release of tumor necrosis factor-alpha that alter brain-like endothelium integrity. PLoS Pathog 2012, 8:e1002632. 10.1371/journal.ppat.1002632, 3315494, 22479186.
34. Belarbi K, Jopson T, Tweedie D, Arellano C, Luo W, Greig NH, Rosi S. TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation. J Neuroinflammation 2012, 25:23.
35. Hasegawa S, Matsushige T, Inoue H, Shirabe K, Fukano R, Ichiyama T. Serum and cerebrospinal fluid cytokine profile of patients with 2009 pandemic H1N1 influenza virus-associated encephalopathy. Cytokine 2011, 54:167-172. 10.1016/j.cyto.2011.01.006, 21371904.
36. Ichiyama T, Morishima T, Isumi H, Matsufuji H, Matsubara T, Furukawa S. Analysis of cytokine levels and NF-kappaB activation in peripheral blood mononuclear cells ininfluenza virus-associated encephalopathy. Cytokine 2004, 27:31-37. 10.1016/j.cyto.2004.03.012, 15207249.
37. Coelho FM, Reis HJ, Nicolato R, Romano-Silva MA, Teixeira MM, Bauer ME, Teixeira AL. Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia. Neuroimmunomodulation 2008, 15:140-144.
38. Londoño D, Carvajal J, Strle K, Kim KS, Cadavid D. IL-10 prevents apoptosis of brain endothelium during bacteremia. J Immunol 2011, 186:7176-7186. 10.4049/jimmunol.1100060, 21602495.
39. van Meurs M, Castro P, Shapiro NI, Lu S, Yano M, Maeda N, Funahashi T, Shimomura I, Zijlstra JG, Molema G, Parikh SM, Aird WC, Yano K. Adiponectin diminishes organ-specific microvascular endothelial cell activation associated with sepsis. Shock 2012, 37:392-398. 10.1097/SHK.0b013e318248225e, 22258235.
40. Venkatesh B, Hickman I, Nisbet J, Cohen J, Prins J. Changes in serum adiponectin concentrations in critical illness: a preliminary investigation. Crit Care 2009, 13:R105. 10.1186/cc7941, 2750144, 19570238.
41. Roberts DJ, Goralski KB, Renton KW, Julien LC, Webber AM, Sleno L, Volmer DA, Hall RI. Effect of acute inflammatory brain injury on accumulation of morphine and morphine 3- and 6-glucuronide in the human brain. Crit Care Med 2009, 37:2767-2774. 10.1097/CCM.0b013e3181b755d5, 19865006.
42. Smith MT. Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites. Clin Exp Pharmacol Physiol 2000, 27:524-528. 10.1046/j.1440-1681.2000.03290.x, 10874511.
43. Park GR. Molecular mechanisms of drug metabolism in the critically ill. Br J Anesth 1996, 77:32-49.
44. Skrobik Y, Leger C, Cossette M, Michaud V, Turgeon J. Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors. Crit Care Med 2013, 41:999-1008. 10.1097/CCM.0b013e318275d014, 23385102.
45. Devlin JW, Fraser GL, Joffe AM, Riker RR, Skrobik Y, . Can delirium Assessments Be Accurately Labelled (CABAL) Investigators GROUP The accurate recognition of delirium in the ICU: the emperor's new clothes?. Intensive Care Med 2013, 39:2196-2199. 10.1007/s00134-013-3105-7, 24114318, Can delirium Assessments Be Accurately Labelled (CABAL) Investigators GROUP.
46. Patel SB, Poston J, Pohlman A, Hall JB, Kress JP. Survival in drug relate versus non-drug related delirium. Am J Respir Crit Care Med 2013, 187:A5237.